Skip to content
10-Q

Quarterly Report

ESCALON MEDICAL CORP ESMC

0000862668-25-000006

← back to feed
Filed
Feb 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Feb 13, 2025 7.42M sh
Current Liabilities Q2 2025 · Dec 31, 2024 $2.21M
Current Liabilities Q2 2025 · Jun 30, 2024 $2.67M
Total Liabilities Q2 2025 · Dec 31, 2024 $2.46M
Total Liabilities Q2 2025 · Jun 30, 2024 $2.95M
Current Assets Q2 2025 · Dec 31, 2024 $4.3M
Current Assets Q2 2025 · Jun 30, 2024 $4.4M
Total Assets Q2 2025 · Dec 31, 2024 $4.49M
Total Assets Q2 2025 · Jun 30, 2024 $4.76M
Revenue Q2 2025 · Dec 31, 2024 $3.22M
Revenue Q2 2025 · Dec 31, 2024 $6M
Revenue Q2 2025 · Dec 31, 2023 $2.87M
Revenue Q2 2025 · Dec 31, 2023 $5.81M
Shares Diluted Q2 2025 · Dec 31, 2023 7.42M sh
Shares Diluted Q2 2025 · Dec 31, 2023 7.42M sh
Capex Q2 2025 · Dec 31, 2023 $40.29K
Operating Cash Flow Q2 2025 · Dec 31, 2023 −$438.09K
Stockholders Equity Q2 2025 · Dec 31, 2023 $1.84M
Stockholders Equity Q2 2025 · Sep 30, 2023 $1.91M
Stockholders Equity Q2 2025 · Jun 30, 2023 $1.93M
Eps Diluted Q2 2025 · Dec 31, 2023 −$0.01
Eps Diluted Q2 2025 · Dec 31, 2023 −$0.02
Eps Basic Q2 2025 · Dec 31, 2023 −$0.01
Eps Basic Q2 2025 · Dec 31, 2023 −$0.02
Sga Expense Q2 2025 · Dec 31, 2023 $1.18M
Sga Expense Q2 2025 · Dec 31, 2023 $2.28M
Rd Expense Q2 2025 · Dec 31, 2023 $147.72K
Rd Expense Q2 2025 · Dec 31, 2023 $359.37K
Net Income Q2 2025 · Dec 31, 2023 −$76.32K
Net Income Q2 2025 · Dec 31, 2023 −$97.52K
Net Income Q2 2025 · Sep 30, 2023 −$21.2K
Operating Income Q2 2025 · Dec 31, 2023 −$70.52K
Operating Income Q2 2025 · Dec 31, 2023 −$86.17K
Cost Of Revenue Q2 2025 · Dec 31, 2023 $1.61M
Cost Of Revenue Q2 2025 · Dec 31, 2023 $3.26M